S 30972-1

• CAT Number: I035885
• CAS Number: 209617-63-0
• Molecular Formula: C27H32Cl2N4O5
• Molecular Weight: 563.476
• Purity: 98%
• Synonyms: S 30972-1; S30972-1; S-30972-1
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: Pentanedioic acid, mono(1-(((2-(dimethylamino)ethyl)amino)carbonyl)-5,6-dimethyl-6H-pyrido(4,3-b)carbazol-9-yl) ester, dihydrochloride
• InChI: InChI=1S/C27H30N4O5.2ClH/c1-16-18-10-11-28-25(27(35)29-12-13-30(2)3)20(18)15-21-19-14-17(8-9-22(19)31(4)26(16)21)36-24(34)7-5-6-23(32)33;;/h8-11,14-15H,5-7,12-13H2,1-4H3,(H,29,35)(H,32,33);2*1H
• InChIKey: NSBSOMWCNYNCBD-UHFFFAOYSA-N
• SMILES: O=C(OC1=CC2=C(N(C)C3=C2C=C(C(C(NCCN(C)C)=O)=NC=C4)C4=C3C)C=C1)CCCC(O)=O.[H]Cl.[H]Cl

S 30972-1 is a S16020-2 derivative that is more efficient in vivo than S16020-2, a feature that may relate to the fact that S30972-1 is less toxic than S16020-2.

Reference

1: Kraus-Berthier L, Guilbaud N, Léonce S, Parker T, Genissel P, Guillonneau C, Goldstein S, Atassi G, Pierré A. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug. Cancer Chemother Pharmacol. 2002 Aug;50(2):95-103. Epub 2002 Jun 25. PubMed PMID: 12172972.
2: Malonne H, Farinelle S, Decaestecker C, Gordower L, Fontaine J, Chaminade F, Saucier JM, Atassi G, Kiss R. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1. Clin Cancer Res. 2000 Sep;6(9):3774-82. PubMed PMID: 10999772.